This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Multivir Inc., Northshore University Healthsystem. Active years: 2025-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025-2026
Title: The Innovative Contributions of Kerstin B Menander
Introduction
Kerstin B Menander is a notable inventor based in Houston, TX, who has made significant strides in the field of cancer treatment. With a focus on tumor suppressor gene therapy, her work aims to enhance the efficacy of cancer therapies through innovative methods and compositions.
Latest Patents
Kerstin holds a patent for "Methods and compositions comprising tumor suppressor gene therapy and CD122/CD132 agonists for the treatment of cancer." This patent outlines methods for treating cancer by administering an effective amount of at least one CD122/CD132 agonist, an immune checkpoint inhibitor, and a viral composition engineered to overexpress a tumor suppressor gene. The treatments described in her patent have shown promising results, leading to complete tumor remissions in highly aggressive forms of cancer that are typically resistant to immune therapies.
Career Highlights
Kerstin is associated with Multivir Inc., where she continues to develop her groundbreaking research. Her dedication to advancing cancer treatment has positioned her as a key figure in the field of medical innovation.
Collaborations
Kerstin collaborates with Dora Wiederhold, who is also involved in the research and development of cancer therapies. Their partnership exemplifies the importance of teamwork in achieving significant advancements in medical science.
Conclusion
Kerstin B Menander's contributions to cancer treatment through her innovative patent and collaboration with fellow researchers highlight her commitment to improving patient outcomes. Her work continues to inspire advancements in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
